PLLA | L10012A | Injectable Poly-l-lactic Acid

L10012A | PLLA  is an acid terminated Pharma / Medical Grade homopolymer of L-lactide with an inherent viscosity midpoint of 1.0 dl/g. It is supplied in the form of white micronized powder. L10012A is primarily used for Drug delivery formulations, Drug-eluting stents, ACL Scrow, and bio-stimulatory dermal filler.

 

Product Description

CAS Number26100-51-6
Systematic NamePoly(2-hydroxy propionic acid), Polylactic acid, Poly lactide, Poly L lactide, Injectable Poly-l-lactic Acid, Ultra-Pure PLLA.
Molecular Formula((C3H4O2)n
EPA Registry NamePolylactic acid
Former CAS Number(s):1104201-86-6, 31587-11-8, 1148011-07-7, 947236-64-8, 1384255-85-9
Substance TypePLA | L10012A | Inherent Viscosity : 0.90 - 1.20 dL/g | Acid terminated |L- Lactide 100% | Mw 100-140 kDa Biodegradable Polymer, Excipient, Non-Active pharmaceutical ingredient, Nanoparticles.
SynonymPLA, Poly(L-lactide) acid terminated, PLLA
ApplicationsDrug delivery formulations, Drug-eluting stents, ACL Scrow, bio-stimulatory dermal filler.

GET QUOTE

Specification

Appearance White powder.
Solubility Soluble in methylene chloride. Insoluble in water.
FT NMR (PROTON) Should comply
Viscosity (0.5% in CHCl3 at 30°C) Between 0.90-1.20 dL/g
Residual monomer L-Lactide ≤ 0.5 %
Residual solvent acetone ≤ 0.1 %
Residual solvent toluene ≤ 890 PPM
Total Residual solvent ≤ 1000 PPM
Acid number 8 - 15 mg KOH/g
Heavy metal ≤ 10 PPM
Tin ≤ 200 PPM
Particle size ≤ 5 µ
Sulphated Ash ≤ 0.1 %
TAMC ≤ 2000 CFU/g
TYMC ≤ 200 CFU/g
Bacterial Endotoxins ≤ 2000 EU/g
Self life 2 Years
See also:PLLA